SpeedTCR - Unlocking the discovery of TCRs for HLA-peptide based and other precision cancer therapies
Lead Participant:
EXOGENE LIMITED
Abstract
SpeedTCR - Unlocking the discovery of TCRs for HLA-peptide based and other cancer therapies
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| EXOGENE LIMITED | £586,208 | £ 351,725 |
Participant |
||
| INNOVATE UK |
People |
ORCID iD |
| Andrea Mambrini (Project Manager) |